Endocalyx in Treatment Resistent Hypertension
Glycocalyx Restoration in Treatment Resistant Hypertension: a Proof of Concept, Randomized, Double-blind, Placebo-controlled Study
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
64 participants
Jan 21, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
4 capsules once daily OR 2 capsules twice daily
4 capsules once daily OR 2 capsules twice daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06940011